BIOMARKERS EUROPE 2024

Gain insights into Biomarker approaches & accelerate timelines in drug development for oncology and immuno-related therapies

Formed of the 3rd Annual Biomarkers Europe and 2nd Annual Precision Oncology Europe Congresses, Biomarkers Europe 2024 is focused on driving the advancement of biomarkers within the fields of oncology and immunotherapy.

The co-located events provide a specialized platform to explore the most innovative technologies and approaches for biomarker validation & Identification, biomarker analysis, applications in precision oncology & patient treatment in clinical trials.

With over 50 presentations, these two-day congresses provide multiple opportunities for engaging scientific insights, valuable networking, and interactive panel & workshop discussions.

Over 500 leading industry experts and clinicians will engage on biomarker end points, personalised patient treatment and companion diagnostics development including early detection technologies & liquid biopsies.

Addressing challenges in biomarker analysis to accelerate timelines in drug development including the role of safety and efficacy biomarkers . Discover novel approaches into optimising biomarker analysis through effective assay development, as well as utilising the latest multiplexed tools impacting biomarker research and validation.

Acquire knowledge about how biomarker approaches are utilized in drug discovery and translational sciences for oncology and immuno-related therapies.

Explore how companies accelerate timelines and reduce risk in drug development. Presentations consider the latest applications of Biomarker Analysis – Multiplex Technology Application & Translational Research in oncology & Immunological disorders

Gain insights into emerging bioanalysis approaches, assay development, and what can be translated in the clinic

Bringing together experts In Oncology And Cancer Care, Clinical Research, and Drug Development To Explore application in diagnosis, stratification & prognosis in oncology, and advancing personalized treatment to improve patient outcomes.

Showcasing the latest technologies and clinical studies in multi-cancer early detection and minimal residual disease testing

Learn about molecular characterization of tumour for targeted therapy selection

Explore biomarker and companion diagnostics discovery, and development

Gain insights from genomics-enabled clinical trials for tailored cancer drug development

Join leaders, experts and researchers at the 3rd Annual Spatial Biology Europe Congress, connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies. Forward looking visionary leaders will discuss the current state of the industry, market trends and future growth areas aiding the application of spatial technologies in the clinic.

Take a deep dive into image analysis, AI-powered imaging, and utilising digital pathology for spatial biology. Key opinion leaders will be providing insights into computational image analysis, multiplexed digital pathology, and the utilisation of AI & machine learning within spatial transcriptomic studies

Discuss the latest innovations in spatial bioinformatics and data analytics. Presentations will delve into the use of spatial data in biology, modelling cell-cell communications, and computational algorithms for spatial analysis. A focused workshop will investigate how to overcome the challenges of spatial data integration

Gain comprehensive insights into novel application areas for spatial biology. This event will cover the applications of spatial data across a variety of therapeutic areas including neuroimmunology, oncology, cardiology and more. Discussions will also involve strategies for making spatially targeted therapeutics more precise

Hear from leading innovators utilizing spatial biology in pharma. See how leading pharmaceutical companies are beginning to integrate spatial biology into R&D to accelerate timelines and move towards the clinic

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programmed, attendees can engage in a variety of event features and make the most of participation in a range of experiences.

• How To Overcome Challenges in Image Analysis for Spatial Biology w/ Lorenz Rognoni, Ultivue
• A role for HALO® in characterizing cell heterogeneity across organ systems: from the liver to the brain
• BIOMARKERS US 2024
• DIGITAL PATHOLOGY 101
• Are image analysis algorithms for digital pathology compliant with regulatory requirements?